XML 18 R8.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated statements of shareholders' equity - USD ($)
$ in Thousands
Common stock
Additional paid-in capital
Accumulated other comprehensive income (loss)
Retained deficit
Total
Common stock, par value (in dollars per share)         $ 0.01
Balance at the beginning of period at Mar. 28, 2020 $ 483 $ 866,667 $ (36,295) $ (559,147) $ 271,708
Balance (in shares) at Mar. 28, 2020 48,316,559        
Increase (Decrease) in Stockholders' Equity          
Net income       (16,670) (16,670)
Stock-based compensation   832     832
Vesting of restricted stock awards $ 2 (2)      
Vesting of restricted stock awards (in shares) 174,758        
Taxes related to net share settlement of restricted stock awards   (165)     (165)
Foreign currency translation adjustment     3,583   3,583
Unrealized gain (loss) on financial instruments, net of tax provision (benefit)     3,961   3,961
Pension liability adjustment     (219)   (219)
Balance at the end of period at Jun. 27, 2020 $ 485 867,332 (28,970) (575,817) 263,030
Balance (in shares) at Jun. 27, 2020 48,491,317        
Balance at the beginning of period at Mar. 28, 2020 $ 483 866,667 (36,295) (559,147) 271,708
Balance (in shares) at Mar. 28, 2020 48,316,559        
Increase (Decrease) in Stockholders' Equity          
Net income         23,199
Foreign currency translation adjustment         12,454
Unrealized gain (loss) on financial instruments, net of tax provision (benefit)         11,800
Pension liability adjustment         (697)
Balance at the end of period at Dec. 26, 2020 $ 486 870,739 (12,738) (535,948) $ 322,539
Balance (in shares) at Dec. 26, 2020 48,573,694        
Common stock, par value (in dollars per share)         $ 0.01
Balance at the beginning of period at Jun. 27, 2020 $ 485 867,332 (28,970) (575,817) $ 263,030
Balance (in shares) at Jun. 27, 2020 48,491,317        
Increase (Decrease) in Stockholders' Equity          
Net income       20,200 20,200
Stock-based compensation   1,836     1,836
Vesting of restricted stock awards $ 1 (1)      
Vesting of restricted stock awards (in shares) 78,963        
Foreign currency translation adjustment     2,446   2,446
Unrealized gain (loss) on financial instruments, net of tax provision (benefit)     1,920   1,920
Pension liability adjustment     (137)   (137)
Balance at the end of period at Sep. 26, 2020 $ 486 869,167 (24,741) (555,617) $ 289,295
Balance (in shares) at Sep. 26, 2020 48,570,280        
Common stock, par value (in dollars per share)         $ 0.01
Increase (Decrease) in Stockholders' Equity          
Net income       19,669 $ 19,669
Stock-based compensation   1,583     1,583
Vesting of restricted stock awards (in shares) 3,414        
Taxes related to net share settlement of restricted stock awards   (11)     (11)
Foreign currency translation adjustment     6,425   6,425
Unrealized gain (loss) on financial instruments, net of tax provision (benefit)     5,919   5,919
Pension liability adjustment     (341)   (341)
Balance at the end of period at Dec. 26, 2020 $ 486 870,739 (12,738) (535,948) $ 322,539
Balance (in shares) at Dec. 26, 2020 48,573,694        
Common stock, par value (in dollars per share)         $ 0.01
Common stock, par value (in dollars per share)         $ 0.01
Balance at the beginning of period at Apr. 03, 2021 $ 488 873,048 (19,003) (500,864) $ 353,669
Balance (in shares) at Apr. 03, 2021 48,838,261        
Increase (Decrease) in Stockholders' Equity          
Net income       17,672 17,672
Stock-based compensation   869     869
Stock option exercises $ 1 225     226
Stock option exercises (in shares) 52,183        
Vesting of restricted stock awards $ 5 (5)      
Vesting of restricted stock awards (in shares) 526,771        
Taxes related to net share settlement of restricted stock awards   (3,677)     (3,677)
Foreign currency translation adjustment     703   703
Unrealized gain (loss) on financial instruments, net of tax provision (benefit)     143   143
Pension liability adjustment     (57)   (57)
Balance at the end of period at Jul. 03, 2021 $ 494 870,460 (18,214) (483,192) 369,548
Balance (in shares) at Jul. 03, 2021 49,417,215        
Balance at the beginning of period at Apr. 03, 2021 $ 488 873,048 (19,003) (500,864) 353,669
Balance (in shares) at Apr. 03, 2021 48,838,261        
Increase (Decrease) in Stockholders' Equity          
Net income         58,560
Foreign currency translation adjustment         (3,649)
Unrealized gain (loss) on financial instruments, net of tax provision (benefit)         (2,105)
Pension liability adjustment         114
Balance at the end of period at Jan. 01, 2022 $ 496 873,088 (24,643) (442,304) $ 406,637
Balance (in shares) at Jan. 01, 2022 49,618,747        
Common stock, par value (in dollars per share)         $ 0.01
Balance at the beginning of period at Jul. 03, 2021 $ 494 870,460 (18,214) (483,192) $ 369,548
Balance (in shares) at Jul. 03, 2021 49,417,215        
Increase (Decrease) in Stockholders' Equity          
Net income       27,195 27,195
Stock-based compensation   1,086     1,086
Vesting of restricted stock awards $ 1 (1)      
Vesting of restricted stock awards (in shares) 127,938        
Foreign currency translation adjustment     (2,022)   (2,022)
Unrealized gain (loss) on financial instruments, net of tax provision (benefit)     (1,161)   (1,161)
Pension liability adjustment     72   72
Balance at the end of period at Oct. 02, 2021 $ 495 871,545 (21,325) (455,997) $ 394,718
Balance (in shares) at Oct. 02, 2021 49,545,153        
Common stock, par value (in dollars per share)         $ 0.01
Increase (Decrease) in Stockholders' Equity          
Net income       13,693 $ 13,693
Stock-based compensation   1,204     1,204
Stock option exercises $ 1 339     340
Vesting of restricted stock awards (in shares) 73,594        
Foreign currency translation adjustment     (2,330)   (2,330)
Unrealized gain (loss) on financial instruments, net of tax provision (benefit)     (1,087)   (1,087)
Pension liability adjustment     99   99
Balance at the end of period at Jan. 01, 2022 $ 496 $ 873,088 $ (24,643) $ (442,304) $ 406,637
Balance (in shares) at Jan. 01, 2022 49,618,747        
Common stock, par value (in dollars per share)         $ 0.01